27 Sep, 2026
Twenty-five years ago, as the country still reeled from Sept. 11, the first of two batches of anthrax-laden envelopes were mailed from New Jersey to news media and congressional offices.…
WASHINGTON — Heidi Overton, President Trump’s nominee to lead the Food and Drug Administration, was grilled by senators on hot button topics like China, vaccines, and abortion access in her…
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter and the afternoon…
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on…
A federal judge on Monday issued a preliminary injunction blocking the Trump administration from upending a long-standing policy that allows foreign students and scholars to stay in the U.S. for…

FDA, NIH unveil new rules to reduce animal testing in drug development

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter and the afternoon Pharmalot newsletter. For the second time this year, the Department of Health and Human Services announced a new set of strategies to speed a shift […]

3 mins read

Radiopharma companies merge after one receives surprise FDA rejection

Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis.01. ITM Isotope Technologies Munich SE and Telix Pharmaceuticals, two leading companies in the burgeoning radiopharmaceuticals field, are merging in a deal worth […]

2 mins read

What’s the real difference between M.D.s and D.O.s?

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them. You can submit a […]

19 mins read